Physician profile
Richard L Dicicco
NPI 1811989874
$964,392.62
in general payments reported to CMS, 2019-2025
14 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150K · 2020: $125K · 2021: $189K · 2022: $163K · 2023: $150K · 2024: $115K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $256K · Travel and Lodging: $36K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $14K · Consulting Fee: $7,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $255,850.00 |
| Travel and Lodging | $35,521.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,250.00 |
| Food and Beverage | $14,076.69 |
| Consulting Fee | $7,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $936,898.33 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Conmed Corporation | $22,502.44 | 2019-2024 | Airseal |
| Gyrus Acmi, INC. | $1,815.00 | 2020 | |
| W. L. Gore & Associates, INC. | $1,032.76 | 2022-2024 | Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Teleflex LLC | $644.42 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Karl Storz Endoscopy-America | $493.24 | 2020-2023 | |
| Novo Nordisk INC | $265.76 | 2023-2025 | Wegovy |
| Ethicon US, LLC | $254.83 | 2019-2024 | Echelon Flex |
| Baxter Healthcare | $125.00 | 2021 | |
| Medtronic, INC. | $107.72 | 2023-2024 | Signia |
| Integra Lifesciences Corporation | $94.26 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Endo Pharmaceuticals INC. | $67.00 | 2020-2021 | |
| Reshape Lifesciences INC. | $66.90 | 2023 | |
| Lilly USA, LLC | $24.96 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dicicco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.